Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Bullboard Posts
Comment by CanadaCoinon Aug 21, 2019 6:47pm
61 Views
Post# 30052705

RE:Canadacoin

RE:Canadacoin
JAYZ555 wrote:
They say that time is money, and for you to be spending this much of it doing what you do, you come off at best someone paid to spew negitivity....


Sorry, but this forum is not about me. I would much rather stay on subject.  

Was there anything in my post that was not factual Jay? Exactly! So how can you suggest that I spew negitivity? May I strongly suggest that you contact your CEO and ask him the following pointed questions...

1) Why did you tells us [shareholders] that the $4.6 million 2018 Private Placement shares were going to have a four month hold, when you knew full well that you were putting that Placement through as a "consulting exemption" placement? 

2) Why on earth did our little penny stock need $2.7 million in Investor relations/consulting, when the Research and Development department was in dire need of funding to advance real shareholder value?

3) Why did you not perform even the smallest amount of due diligence on your $2.7 milliion Investor Relations contractors....such as visiting their [non-existent] websites? 


Bullboard Posts